EdwardLPesantiMD

PubMed

• 244 citations
  Persistent and relapsing babesiosis in immunocompromised patients.
  Peter J. Krause, Benjamin E. Gewurz, David R. Hill, Francisco M. Marty, Edouard Vannier
  Clinical Infectious Diseases. 2008-02-01
• 145 citations
  Intravenous Immunoglobulin Therapy for Toxic Shock Syndrome
  William Barry, Luanne Hudgins, Sam T. Donta, Edward L. Pesanti
  JAMA. 1992-06-24
• 100 citations
  IMMUNOLOGIC DEFECTS AND VACCINATION IN PATIENTS WITH CHRONIC RENAL FAILURE
  Edward L. Pesanti
  Infectious Disease Clinics of North America. 2001-09-01

Journal Articles

• Antiretroviral Treatment Regimen Outcomes Among HIV-Infected Prisoners  
  Springer SA, Friedland GH, Doros G, Pesanti E and Altice FL, Clin Trials, 1/1/2007
• Chronic Osteomyelitis: results obtained by an integrated team approach to management  
  Salvana J, Rodner C, Browner BD, Livingston K, Schreiber J, Pesanti E, Connecticut Med, 1/1/2005
• Effectiveness of Antiretroviral Therapy among HIV-Infected Prisoners: Reincarceration and the Lack of Sustained Benefit after Release to the Community  
  Springer SA, Pesanti E, Hodges J, Macura T, Doros G, Altice FL, Clin Infect Dis, 1/1/2004
• Immunologic defects and vaccination in patients with chronic renal failure  
  Pesanti E, Infect Dis Clin NA, 1/1/2001
• Episodic spontaneous hyperhidrosis with hypothermia in HIV-virus positive patients  
  Okechukwu CN, Pesanti E, Clin Infect Dis, 1/1/1999
• Cellular events in the development of chronic osteomyelitis  
  Pesanti EL, Lorenzo J, Clin Orthop, 1/1/1998
• Mantle-cell lymphoma in a patient with Human Immunodeficiency viral infection  
  Bilgrami S, Shafi N, Cieselski T, Singh NT, Chen LL, Synnott V, Acta Haematol, 1/1/1995
• Book Review of: Tuberculosis: Clinical Management and New Challenges by Rossman MD, MacGregor RR  
  Pesanti EL, Ann Int Med, 1/1/1995
• Raised prostate-specific antigen in adenocarcinoma of lung  
  Bilgrami S, Singh NT, Shafi N, Pesanti EL, Lancet, 1/1/1994
• The negative tuberculin test Tuberculosis, HIV, and anergy panels  
  Pesanti EL, Am J Resp Crit Care Med, 1/1/1994
• The challenge of Pneumocystis culture  
  Hughes W, Armstrong M, Bartlett M, Blumenfeld W, Cushion M, Kalica A, Kovacs J, Laughon G, Martin W, Pesanti E, Richards F, Rose R, Sloand E, Walzer P, J Euk Microbiol, 1/1/1993
• Intravenous immunoglobulin therapy for toxic shock syndrome  
  Barry W, Hudgins L, Donta ST, Pesanti EL, JAMA, 1/1/1992
• An update on resistant tuberculosis and the threat to health care workers  
  Pesanti EL, Asepsis, 1/1/1992
• Binding of I125-labelled tumor necrosis factor- (TNF) to Pneumocystis carinii and insoluble cell wall fraction  
  Pesanti EL, Tomicic T, Donta ST, J Protozool, 1/1/1991
• Effects of cytokines and macrophage secretory products on in vitro viability of Pneumocystis carinii  
  Pesanti EL, J Infect Dis, 1/1/1991
• Interaction of Pneumocystis carinii with secretions of alveolar macrophages and type II epithelial cells  
  Pesanti EL, J Protozool, 1/1/1989
• Enzymes of Pneumocystis carinii: electrophoretic mobility on starch gels  
  Pesanti EL, J Protozool, 1/1/1989
• Ornithine decarboxylase: lack of detectable activity in Pneumocystis carinii  
  Pesanti EL, Bartlett MS, Smith JW, J Infect Dis, 1/1/1988
• Glycoproteins of Pneumocystis carinii  
  Pesanti EL, J Infect Dis, 1/1/1988
• A method for rapid separation of Pneumocystis carinii from lung lavage fluids  
  Pesanti EL, McCarron BA, J Clin Micro, 1/1/1988
• Infection with human immunodeficiency virus (HIV) as a risk factor for bacteremic illness due to Streptococcus pneumoniae  
  Pesanti EL, Lyons RW, Verilli M, Levitz R, Brettman L, Conn Med, 1/1/1988
• Pneumocystis carinii: phosphoipid profile and interaction with alveolar type II epithelial cells  
  Pesanti EL, Infect Immun, 1/1/1987
• Influence of ventilation mode and body temperature on pulmonary clearance of S aureus  
  Frederick D, Pesanti EL, Infect Immun, 1/1/1987
• Murine cytomegalovirus adrenalitis in athymic nude mice  
  Shanley EL, Pesanti EL, Arch Virology, 1/1/1986
• The relation of virus replication to interstitial pneumonitis in murine cytomegalovirus lung infection  
  Shanley JD, Pesanti EL, J Infect Dis, 1/1/1985
• Join now to see all

Books/Book Chapters

• Musculoskeletal Emergencies 
  Chapter: Infections involving the musculoskeletal system. 
  Page 23 - 26Kadakia A, Mondragon CFG, Pesanti ELEditors: Browner BD and Fuller RP.Elsevier Saunders2013
• Skeletal Trauma 
  Chapter: Chronic osteomyelitis. 
  Page 482 - 506Rodner CM, Browner BD, Pesanti ELEditors: Browner BD, Levine AM, Jupiter JB and Trafton PG.Saunders2003
• Emergency Care and Transportation of the Sick and Injured 
  Chapter: Communicable Diseases. 
  Pesanti EEditors: Browner BD, Jacobs LM, Pollak AN.1998
• Conn's Current Therapy 
  Chapter: Tuberculosis and other mycobacterial diseases. 
  Singh NT, Pesanti ELEditors: Rakel RE.1996
• Tuberculosis: a clinical manual. 
  Chapter: The therapy of tuberculosis: a history. 
  Pesanti ELEditors: Lutwick LL.Chapman & Hall, Ltd, London1994
• Pneumocystis carinii Pneumonia 
  Chapter: Host effector mechanisms in immunity to Pneumocystis carinii. 
  Pesanti ELEditors: Walzer PD.Marcel Dekker1993
• Conn's Current Therapy 
  Chapter: Treatment of tuberculosis and other mycobacterial infections. 
  Page 146 - 153Pesanti ELEditors: R. Rakel.W.B. Saunders Company, New York, NY1985
• Functional Aspects of Mononuclear Phagocytes. 
  Chapter: Effects of oxygen on metabolic patterns and endocytosis of macrophages. 
  Axline SG, Simon LM, Robin ED, Pesanti ELEditors: R vanFurth. Martinus Nijhoff.Boston, MA1980
• Join now to see all

Other

• Pneumocystis carinii. 
  Pesanti EL, Clinical Microbiology Newsletter
  1/1/1987